From a blog by VALID advisor Christian Sillaber, Senior Researcher on IT-Security
The European Union’s General Data Protection Regulation (GDPR) came into effect on May 25, 2018. It is already clear that the new law, which is in many respects ground-breaking, is struggling to keep up with the pace of technological change. If this issue is not addressed, the GDPR will undermine citizens’ ability to use blockchain.
The core of the problem is that, in addition to the explicit declaration of the rights of the data subject (access to data, data portability, right to erasure, right to correction etc.), the GDPR also mandates that data controllers and processors abide by the principle of “data protection by design and default”. This means designing services and software with privacy as a foundational consideration rather than as an afterthought or add-on. The implied design requirements and goals seem to be at odds with the fundamental ideas behind blockchain and other emerging distributed ledger technologies — in particular transparency, immutability and egalitarian access to the data.
The GDPR applies to the processing of personal data (Art. 2 para. 1 GDPR), that is, any information relating to an identified or — by the use of additional information — identifiable person (Art. 4 para. 1 GDPR). Although the cryptographic identities used by most participants of public permissionless distributed ledger systems are not directly linked to identified natural persons, it is — under certain circumstances — possible to identify participants through additional information (e.g. correlation of the person’s activities with third party data). Therefore, data stored and processed in most public, permissionless blockchain systems should be considered personal data. Little doubt also remains that territorial applicability can also be established for most distributed ledger systems, as they are either (partially) operated from within the EU or are actively used to process data from data subjects located in the EU.
Public, permissionless distributed ledger systems enable their participants to maintain a public database without the need for a trusted central authority or mutual trust. Any participant may enter or leave the system at any time and, therefore, access the data of the ledger at any time.
Image Credit: Valid
News This Week
Omicron subvariant BA.2 replicates faster in brain cells than other strains, study finds
Omicron subvariant BA.2 – which was dominant worldwide early this year, including in Hong Kong – replicates more swiftly than other strains and causes faster programmed cell death in human brains, a new study has found. [...]
Seeding the oceans with iron-rich fertilizer nanoparticles to store excess carbon dioxide
The urgent need to remove excess carbon dioxide from Earth’s environment could include enlisting some of our planet’s smallest inhabitants, according to an international research team led by Michael Hochella of the Department of [...]
Temporary graphene ‘tattoos’ that measure blood pressure
Blood pressure is a key vital sign that provides insight into our cardiovascular health. But blood pressure is typically measured only a few times per year by a clinician—and these measurements might not always [...]
Next Covid-19 Strain May be More Dangerous, Lab Study Shows
A South African laboratory study using Covid-19 samples from an immunosupressed individual over six months showed that the virus evolved to become more pathogenic, indicating that a new variant could cause worse illness than [...]
The Fast-Spreading New COVID-19 Subvariant XBB Is Part of a ‘New Class’ of Omicron
For the past several months, Omicron subvariants BA.4 and BA.5 have dominated COVID-19 cases in the U.S. But now, there’s a class of new COVID subvariants on the rise and one in particular is getting plenty of [...]
Overcoming challenges in the delivery of nucleic acid therapeutics
Nucleic acid therapies involving DNA or RNA have significant potential to treat genetic disorders, infectious diseases, and cancer; however, research suggests that less than 1% of injected nucleic acid doses reach target cells in [...]
FDA approves $3.5 million treatment for hemophilia, now the most expensive drug in the world
The US Food and Drug Administration on Tuesday approved Hemgenix, a new drug to treat hemophilia. Manufacturer CSL Behring set the price at $3.5 million per treatment, making it the most expensive drug [...]
Wireless smart bandage promotes faster closure of wounds, enhances skin recovery
Some wounds just won’t heal. Infections, diseases like diabetes, and suppressed immune systems often stack up to slow healing. Chronic wounds can last months and lead to anxiety and depression. In the worst cases, [...]
Leave A Comment